Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2023-05-24
2024-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Influence of Different At-home Exercise Strategies on 24h Glycemic Control
NCT05490706
Medium Chain Triglycerides and Aerobic Exercise on Ketone Production in Women With or Without Prediabetes
NCT02678390
Effects of Resistance Exercise on Blood Glucose in Post-menopausal Women With Type 1 Diabetes
NCT05203640
Comparing the Effects of Different Types of Exercise on Glucose Handling
NCT06217679
Exercise Timing and Gestational Diabetes
NCT05256615
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Eligible participants will be assigned, in a random order, to two metabolic trials approximately 4 weeks apart that involve 4 days of controlled diet and exercise. Each trial takes place over 4 days, but participants are not required to come to the laboratory on all days. The two trials involve: 1) Exercise + Greek Yogurt (GY) 2) Exercise + a carbohydrate-based study supplement (SS).
During the 4 day trials, participants consume controlled diets and the study supplements (GY and SS). On 1 of these days participants will perform exercise in our lab followed by the consumption of GY or SS. Various outcomes will be measured throughout the trial, including glycemic control (via continuous glucose monitoring), fat oxidation, appetite and health outcomes in blood samples.
Throughout the duration of the study, participants will be asked to maintain their habitual diet and physical activity patterns, and maintain their current body weight.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High-intensity interval exercise and post-exercise Greek yogurt (HIIE+GY)
Participants will consume greek yogurt following a single session of exercise
Greek yogurt
Following 2 days of controlled diet, participants will consume greek yogurt following high-intensity interval exercise
Exercise
Following 2 days of controlled diet, participants will perform high-intensity interval exercise following an overnight fast
High-intensity interval exercise and post-exercise carbohydrate study supplement (HIIE +SS)
Participants will consume a carbohydrate-based study supplement following a single session of exercise
Carbohydrate-based study supplement
Following 2 days of controlled diet, participants will consume a carbohydrate-based study supplement following high-intensity interval exercise
Exercise
Following 2 days of controlled diet, participants will perform high-intensity interval exercise following an overnight fast
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Greek yogurt
Following 2 days of controlled diet, participants will consume greek yogurt following high-intensity interval exercise
Carbohydrate-based study supplement
Following 2 days of controlled diet, participants will consume a carbohydrate-based study supplement following high-intensity interval exercise
Exercise
Following 2 days of controlled diet, participants will perform high-intensity interval exercise following an overnight fast
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI ≥27 kg/m2
* Elevated waist circumference (≥88 cm)
* ≤2 structured exercise sessions/week
* Weight stable (within ± 2kg for at least 6 months)
* Experiencing regular natural menstrual cycles
* Non-smoker
Exclusion Criteria
* Diagnosed lactose intolerance or an aversion to foods provided during the study (e.g., post-exercise snacks)
* Previous history of cardiovascular or metabolic disease
* The use of medication for managing blood glucose or lipid metabolism
* Current use of oral contraceptives or use within the last 3 months
* Irregular menstrual cycles (\<21 days or \>35 days)
* Pregnant or lactating
* Recreational tobacco or cannabis use
* Inability to perform the study exercise protocols
* Actively engaging in a low-carbohydrate diet (e.g., ketogenic, Atkins).
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jenna Gillen
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jenna Gillen, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Toronto
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jenna Gillen
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
42756-3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.